Bladder cancer
Conditions
Interventions
Treatment Group:Epirubicin bladder instillation + taking Bangan Bazheng granules for 12 months: Each time epirubicin bladder instillation + taking Bangan Bazheng granules for 1 week (3 times a day)
Control group:Epirubicin intravesical instillation for 12 months
Sponsors
The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: (1) Patients aged 18 to 70 years; (2) Patients diagnosed with non-muscle invasive bladder cancer (Ta T1) by clinical imaging combined with TURBT; (3) Patients must meet the TCM syndrome diagnostic criteria for damp-heat type; (4) Signed informed consent and good compliance.
Exclusion criteria
Exclusion criteria: (1) Women who are pregnant or preparing to become pregnant or breastfeeding; (2) Patients with obvious major diseases such as serious cardiovascular and cerebrovascular diseases nervous system diseases motor organ diseases etc. as well as patients with obvious disabilities or visual and hearing impairments that seriously affect their quality of life; (3) Patients who are allergic to Bangan Bazheng Granules epirubicin or its components should be excluded to ensure the safety of the study; (4) Patients who are participating in clinical studies of other drugs should not be included in this study to avoid drug interactions and the complexity of evaluation; (5) Patients with other systemic malignant tumors; (6) Patients with autoimmune diseases;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cystoscopy(Proportion of subjects who relapsed bladder cancer within 1 year of treatment); | — |
Secondary
| Measure | Time frame |
|---|---|
| Traditional Chinese Medicine Syndrome Points;Urinary ultrasound (residual urine);ICIQ-M/F-LUTS;Urine flow rate; | — |
Countries
China
Contacts
Public ContactKaifa Tang
The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine
Outcome results
None listed